TD Synnex Q1 2026 slides: gross billings jump 24% on hyperscaler demand

TD Synnex reported Q1 FY2026 non-GAAP gross billings of $25.8B (+24% YoY) and revenue of $17.2B (+18% YoY), with non-GAAP diluted EPS of $4.73 (+69% YoY) that beat consensus by ~42.5% and revenue by ~10.1%. Hyve Solutions surged—gross billings ~$3.8B (+95% YoY) and operating income $159M (+66% YoY)—while Global Distribution posted $22.0B (+17% YoY) and operating income $431M (+42% YoY); consolidated operating margin improved 37 bps to 2.29% of gross billings. Management guided Q2 to non-GAAP gross billings ~$25.1B (+16% YoY), revenue ~$16.5B (+10% YoY) and EPS ~$4.00 (+34% YoY); balance sheet and cash flow remain healthy (TTM FCF $1.2B, cash $1.6B, net leverage 1.5x) and the company returned $118M to shareholders in the quarter.

Analysis

Treat the company as a bifurcated business: a broad, low-margin distribution engine and a nascent, high-margin systems/assembly franchise. The latter can disproportionately move consolidated margins and valuation even as it remains a smaller top-line contributor, so investors should revalue profitability per dollar of new bookings rather than headline revenue growth alone.

Second-order supply-chain winners include contract test/assembly firms, server component suppliers and specialty logistics providers — they pick up margin as Hyve scales assembly and supply-chain services. Conversely, pure-play distributors and smaller VARs face margin compression and share loss as hyperscalers prefer single-source solutions with embedded integration and logistics capabilities.

Key near-term catalysts are hyperscaler program ramps and inventory turns at quarter-ends; medium-term drivers are multi-year hyperscale AI capex cycles and potential vendor consolidation deals. Tail risks are concentrated: an AI capex pause, a sudden inventory correction, or trade-route disruptions that lengthen lead times would rapidly reverse operating leverage and amplify working-capital strain.

Market positioning creates actionable option and pair opportunities where upside is asymmetric but idiosyncratic execution risk is real. Time the exposure around the next two earnings prints and vendor program announcements (next 3–12 months) rather than buying into headline momentum; use structures that cap downside while leaving substantial upside participation if Hyve wins further scale or M&A boosts the services footprint.

Key Decisions for Investors

• Directional equity: Tactical long SNX (size 1–2% portfolio) entered on either: (a) a confirmed Q2 guidance beat or (b) an intra-quarter pullback of ~8–12% from recent levels. Target 30–40% upside over 6–12 months; hard stop at -10% to limit capital on execution/inventory risk.
• Defined-risk options: Buy a 6–9 month SNX call-debit spread ~25–35% OTM to capture asymmetric upside from Hyve program ramps while capping premium loss. Expect cost <6% of notional; target 3x P&L if hyperscaler revenues re-rate over the next 9–12 months.
• Pairs trade: Go long SNX / short ARW or CDW (equal notional) over 12 months to play share-shift into integrated assembly/logistics. This isolates Hyve-driven margin expansion vs. commoditized distribution pressure; cut if relative performance reverses by >6% in 60 days.
• Event hedge: If holding SNX into the next earnings release, buy 1/3 notional 9–12 month puts (protect 8–12% downside) financed by selling covered calls (10–20% OTM) to monetize elevated implied vol and reduce net cost.